Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States

Gastroenterology

Volumn 156, Issue 1, 2019, Pages 175-186.e2

  Butt, Julia ^a,b   Varga, Matthew G ^c   Blot, William J ^d   Teras, Lauren ^e   Visvanathan, Kala ^f   Le Marchand, Loïc ^g   Haiman, Christopher ^h   Chen, Yu ⁱ   Bao, Ying ^j   Sesso, Howard D ^j,k   Wassertheil Smoller, Sylvia ^l   Ho, Gloria Y F ^m   Tinker, Lesley E ⁿ   Peek, Richard M ^d   Potter, John D ⁿ   Cover, Timothy L ^o   Hendrix, Laura H ^p   Huang, Li Ching ^d   Hyslop, Terry ^b,p   Um, Caroline ^e   Grodstein, Francine ^k   Song, Mingyang ^k,q   Zeleniuch Jacquotte, Anne ⁱ   Berndt, Sonja ^r   Hildesheim, Allan ^r   Waterboer, Tim ^a   Pawlita, Michael ^a   Epplein, Meira ^b   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b DUKE CANCER INSTITUTE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e AMERICAN CANCER SOCIETY   (Georgia)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^l ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^m DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

ⁿ Fred Hutchinson Cancer Research Center   (United States)

^o VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q MASSACHUSETTS GENERAL HOSPITAL   (United States)

^r NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

Cohort Studies; Epidemiology; Gastrointestinal Cancers

Indexed keywords

ACECAINIDE; ACETYLSALICYLIC ACID; ANTIBODY; CAGA PROTEIN; CATALASE; GLUTATHIONE TRANSFERASE; HYUA PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; OUTER MEMBRANE PROTEIN; UNCLASSIFIED DRUG; UREA; VACUOLATING TOXIN; VIRULENCE FACTOR; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; BIOLOGICAL MARKER; VACA PROTEIN, HELICOBACTER PYLORI;

ADULT; AFRICAN AMERICAN; AGED; ANTIBODY RESPONSE; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; COHORT ANALYSIS; COLON POLYP; COLORECTAL CANCER; DIABETES MELLITUS; FEMALE; HELICOBACTER PYLORI; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNITED STATES; VERY ELDERLY; YOUNG ADULT; ADOLESCENT; BLOOD; CLINICAL TRIAL; COLORECTAL TUMOR; HELICOBACTER INFECTION; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INCIDENCE; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOGENICITY; RISK FACTOR; SEROEPIDEMIOLOGY; VIRULENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BIOMARKERS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES; VIRULENCE; YOUNG ADULT;

EID: 85058455264     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2018.09.054     Document Type: Article

References (41)

1. Plummer, M., de Martel, C., Vignat, J., et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health 4 (2016), e609–e616.
2. Hooi, J.K.Y., Lai, W.Y., Ng, W.K., et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 153 (2017), 420–429.
3. Grad, Y.H., Lipsitch, M., Aiello, A.E., Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities. Am J Epidemiol 175 (2012), 54–59.
4. Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2018. CA Cancer J Clin 68 (2018), 7–30.
5. de Korwin, J.D., Ianiro, G., Gibiino, G., et al. Helicobacter pylori infection and extragastric diseases in 2017. Helicobacter, 22(Suppl 1), 2017.
6. Zhao, Y., Wang, X., Wang, Y., Helicobacter pylori infection and colorectal carcinoma risk: a meta-analysis. J Cancer Res Ther 12 (2016), 15–18.
7. Zumkeller, N., Brenner, H., Zwahlen, M., et al. Helicobacter pylori infection and colorectal cancer risk: a meta-analysis. Helicobacter 11 (2006), 75–80.
8. Blaser, M.J., The biology of cag in the Helicobacter pylori-human interaction. Gastroenterology, 128, 2005 1512–155.
9. Cover, T.L., Helicobacter pylori diversity and gastric cancer risk. MBio, 7, 2016 e01869-15.
10. Epplein, M., Signorello, L.B., Zheng, W., et al. Race, African ancestry, and Helicobacter pylori infection in a low-income United States population. Cancer Epidemiol Biomarkers Prev 20 (2011), 826–834.
11. Epplein, M., Pawlita, M., Michel, A., et al. Helicobacter pylori protein-specific antibodies and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 22 (2013), 1964–1974.
12. Kolonel, L.N., Henderson, B.E., Hankin, J.H., et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 151 (2000), 346–357.
13. Wei, E.K., Giovannucci, E., Fuchs, C.S., et al. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 97 (2005), 1688–1694.
14. Colditz, G.A., Hankinson, S.E., The Nurses’ Health Study: lifestyle and health among women. Nat Rev Cancer 5 (2005), 388–396.
15. Lee, J.E., Wei, E.K., Fuchs, C.S., et al. Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested case-control studies. Cancer Causes Control 23 (2012), 537–545.
16. Toniolo, P.G., Levitz, M., Zeleniuch-Jacquotte, A., et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 87 (1995), 190–197.
17. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 19 (1998), 61–109.
18. Huang, H.Y., Alberg, A.J., Norkus, E.P., et al. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol 157 (2003), 335–344.
19. Calle, E.E., Rodriguez, C., Jacobs, E.J., et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer 94 (2002), 500–511.
20. Hayes, R.B., Reding, D., Kopp, W., et al. Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 21 (2000), 349S–355S.
21. Michel, A., Waterboer, T., Kist, M., et al. Helicobacter pylori multiplex serology. Helicobacter 14 (2009), 525–535.
22. Brim, H., Zahaf, M., Laiyemo, A.O., et al. Gastric Helicobacter pylori infection associates with an increased risk of colorectal polyps in African Americans. BMC Cancer, 14, 2014, 296.
23. Blase, J.L., Campbell, P.T., Gapstur, S.M., et al. Prediagnostic Helicobacter pylori antibodies and colorectal cancer risk in an elderly, Caucasian population. Helicobacter 21 (2016), 488–492.
24. Patel, S., Lipka, S., Shen, H., et al. The association of H. pylori and colorectal adenoma: does it exist in the US Hispanic population?. J Gastrointest Oncol 5 (2014), 463–468.
25. Park, H., Park, J.J., Park, Y.M., et al. The association between Helicobacter pylori infection and the risk of advanced colorectal neoplasia may differ according to age and cigarette smoking. Helicobacter, 2018, e12477.
26. McClain, M.S., Beckett, A.C., Cover, T.L., Helicobacter pylori vacuolating toxin and gastric cancer. Toxins (Basel), 9, 2017.
27. Ferreira, R.M., Machado, J.C., Figueiredo, C., Clinical relevance of Helicobacter pylori vacA and cagA genotypes in gastric carcinoma. Best Pract Res Clin Gastroenterol 28 (2014), 1003–1015.
28. Parsonnet, J., Replogle, M., Yang, S., et al. Seroprevalence of CagA-positive strains among Helicobacter pylori-infected, healthy young adults. J Infect Dis 175 (1997), 1240–1242.
29. Luther, J., Owyang, S.Y., Takeuchi, T., et al. Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis. Gut 60 (2011), 1479–1486.
30. Dunn, B.E., Vakil, N.B., Schneider, B.G., et al. Localization of Helicobacter pylori urease and heat shock protein in human gastric biopsies. Infect Immun 65 (1997), 1181–1188.
31. Snider, C.A., Voss, B.J., McDonald, W.H., et al. Growth phase-dependent composition of the Helicobacter pylori exoproteome. J Proteomics 130 (2016), 94–107.
32. Noto, J.M., Peek, R.M. Jr., The gastric microbiome, its interaction with Helicobacter pylori, and its potential role in the progression to stomach cancer. PLoS Pathog, 13, 2017, e1006573.
33. Konturek, S.J., Konturek, P.C., Hartwich, A., et al. Helicobacter pylori infection and gastrin and cyclooxygenase expression in gastric and colorectal malignancies. Regul Pept 93 (2000), 13–19.
34. Sobhani, I., Lehy, T., Laurent-Puig, P., et al. Chronic endogenous hypergastrinemia in humans: evidence for a mitogenic effect on the colonic mucosa. Gastroenterology 105 (1993), 22–30.
35. Strofilas, A., Lagoudianakis, E.E., Seretis, C., et al. Association of helicobacter pylori infection and colon cancer. J Clin Med Res 4 (2012), 172–176.
36. Thorburn, C.M., Friedman, G.D., Dickinson, C.J., et al. Gastrin and colorectal cancer: a prospective study. Gastroenterology 115 (1998), 275–280.
37. Kountouras, J., Zavos, C., Chatzopoulos, D., et al. New aspects of Helicobacter pylori infection involvement in gastric oncogenesis. J Surg Res 146 (2008), 149–158.
38. Cai, Q., Gao, Y.T., Chow, W.H., et al. Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk. J Clin Oncol 24 (2006), 5010–5016.
39. Bezawada, N., Song, M., Wu, K., et al. Urinary PGE-M levels are associated with risk of colorectal adenomas and chemopreventive response to anti-inflammatory drugs. Cancer Prev Res (Phila) 7 (2014), 758–765.
40. Davenport, J.R., Cai, Q., Ness, R.M., et al. Evaluation of pro-inflammatory markers plasma C-reactive protein and urinary prostaglandin-E2 metabolite in colorectal adenoma risk. Mol Carcinog 55 (2016), 1251–1261.
41. Wang, T., Zhang, Y., Su, H., et al. Helicobacter pylori antibody responses in association with eradication outcome and recurrence: a population-based intervention trial with 7.3-year follow-up in China. Chin J Cancer Res 29 (2017), 127–136.